GlassScriptPhysician profile
Kailey E Tarbell
NPI 1497202931
$493.27
in general payments reported to CMS, 2019-2025
14 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $88.41 · 2023: $13.41 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $101.82 | 2022-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $91.89 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $61.27 | 2021 | |
| Philips North America LLC | $43.58 | 2025 | Vest Therapy Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.23 | 2021-2025 | Jascayd |
| Genzyme Corporation | $21.98 | 2025 | |
| Amgen INC. | $21.20 | 2025 | Tezspire |
| Biohaven Pharmaceuticals, INC. | $20.72 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.50 | 2021 | |
| Grifols USA, LLC | $18.71 | 2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $17.28 | 2025 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $13.85 | 2025 | Breztri |
| Pfizer INC. | $13.71 | 2021 | |
| Glaxosmithkline, LLC. | $13.53 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kailey Tarbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.